Filip Spaniel
Klecany, ST, Czech Republic
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 94 publications
Speech-based relapse prediction in psychosis using explainable AI: Protocol for the international multicentre observational TRUSTING study.
Journal: BMJ open
Published: August 28, 2026
Is Temporal Variability a Standalone Predictor in Medical Data? An Actigraphy Study in Bipolar Disorder.
Journal: Studies in health technology and informatics
Published: May 23, 2026
Individualized cortical gradient and network topology reveal symptom-linked disruptions and neurobiological subtypes in schizophrenia.
Journal: medRxiv : the preprint server for health sciences
Published: May 07, 2026
Medium-term prediction of clinically relevant outcomes in first-episode schizophrenia patients.
Journal: Schizophrenia research
Published: March 25, 2026
Antipsychotics lower peripheral markers of inflammation in drug-naïve early psychosis: a pilot study.
Journal: Frontiers in psychiatry
Published: December 16, 2025
Special Issue: Does latent Toxoplasma infection mimic the immune profile of schizophrenia? Sex-specific cytokine and brain-marker alterations suggest partial overlap.
Journal: Folia parasitologica
Published: October 22, 2025
An ENIGMA Consortium study of the relationship between white matter microstructure and positive and negative symptom severity in patients with schizophrenia.
Journal: Schizophrenia (Heidelberg, Germany)
Published: August 06, 2025
Central Obesity-related Brain Alterations Predict Cognitive Impairments in First Episode of Psychosis.
Journal: Schizophrenia bulletin
Published: July 15, 2025
Infra-slow frequency oscillations propagating through multiple organs convey information on phase-specific timing for self-initiated actions.
Journal: Brain research
Published: June 09, 2025
Beyond dopamine: Exploring anti-inflammatory mechanisms of antipsychotics.
Journal: Progress in neuro-psychopharmacology & biological psychiatry
Published: April 07, 2025
The ILIA study: protocol for a randomized-controlled multicenter clinical trial on smartphone- and web-based relapse monitoring for patients with schizophrenia or schizoaffective disorder.
Journal: European archives of psychiatry and clinical neuroscience
Published: March 24, 2025
Last Updated: 09/26/2026